These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1098 related articles for article (PubMed ID: 33747944)
1. Identification of Stemness Characteristics Associated With the Immune Microenvironment and Prognosis in Gastric Cancer. Mao D; Zhou Z; Song S; Li D; He Y; Wei Z; Zhang C Front Oncol; 2021; 11():626961. PubMed ID: 33747944 [TBL] [Abstract][Full Text] [Related]
2. Immunological Value of Prognostic Signature Based on Cancer Stem Cell Characteristics in Hepatocellular Carcinoma. Xu Q; Xu H; Chen S; Huang W Front Cell Dev Biol; 2021; 9():710207. PubMed ID: 34409040 [No Abstract] [Full Text] [Related]
3. Prognostic Value of a Stemness Index-Associated Signature in Primary Lower-Grade Glioma. Zhang M; Wang X; Chen X; Guo F; Hong J Front Genet; 2020; 11():441. PubMed ID: 32431729 [TBL] [Abstract][Full Text] [Related]
4. Prognostic Prediction Using a Stemness Index-Related Signature in a Cohort of Gastric Cancer. Chen X; Zhang D; Jiang F; Shen Y; Li X; Hu X; Wei P; Shen X Front Mol Biosci; 2020; 7():570702. PubMed ID: 33134315 [TBL] [Abstract][Full Text] [Related]
5. A Risk Signature with Nine Stemness Index-Associated Genes for Predicting Survival of Patients with Uterine Corpus Endometrial Carcinoma. Xu H; Zou R; Liu J; Zhu L J Oncol; 2021; 2021():6653247. PubMed ID: 33747079 [TBL] [Abstract][Full Text] [Related]
6. Construction and Validation of a Prognostic Model Based on mRNAsi-Related Genes in Breast Cancer. Zhao X; Lin J Comput Math Methods Med; 2022; 2022():6532591. PubMed ID: 36267313 [TBL] [Abstract][Full Text] [Related]
7. Development and validation of a hypoxia-stemness-based prognostic signature in pancreatic adenocarcinoma. Tian X; Zheng J; Mou W; Lu G; Chen S; Du J; Zheng Y; Chen S; Shen B; Li J; Wang N Front Pharmacol; 2022; 13():939542. PubMed ID: 35935823 [No Abstract] [Full Text] [Related]
8. Development and validation of a novel stemness-related prognostic model for neuroblastoma using integrated machine learning and bioinformatics analyses. Xia Y; Wang C; Li X; Gao M; Hogg HDJ; Tunthanathip T; Hulsen T; Tian X; Zhao Q Transl Pediatr; 2024 Jan; 13(1):91-109. PubMed ID: 38323183 [TBL] [Abstract][Full Text] [Related]
9. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma. Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Xie Y Front Med (Lausanne); 2022; 9():925661. PubMed ID: 35872794 [TBL] [Abstract][Full Text] [Related]
10. Construction and validation of a novel coagulation-related 7-gene prognostic signature for gastric cancer. Wang B; Zou D; Wang N; Wang H; Zhang T; Gao L; Ma C; Zheng P; Gu B; Li X; Wang Y; He P; Ma Y; Wang X; Chen H Front Genet; 2022; 13():957655. PubMed ID: 36105100 [No Abstract] [Full Text] [Related]
11. Stemness analysis in hepatocellular carcinoma identifies an extracellular matrix gene-related signature associated with prognosis and therapy response. Chen L; Zhang D; Zheng S; Li X; Gao P Front Genet; 2022; 13():959834. PubMed ID: 36110210 [No Abstract] [Full Text] [Related]
12. Comprehensive analysis of immune-related gene signature based on ssGSEA algorithms in the prognosis and immune landscape of hepatocellular carcinoma. Wang L; Wang L; He P Front Genet; 2022; 13():1064432. PubMed ID: 36568383 [No Abstract] [Full Text] [Related]
13. A combined hypoxia and immune gene signature for predicting survival and risk stratification in triple-negative breast cancer. Yang X; Weng X; Yang Y; Zhang M; Xiu Y; Peng W; Liao X; Xu M; Sun Y; Liu X Aging (Albany NY); 2021 Aug; 13(15):19486-19509. PubMed ID: 34341184 [TBL] [Abstract][Full Text] [Related]
14. Identification of a pyroptosis-related prognostic signature in breast cancer. Chen H; Luo H; Wang J; Li J; Jiang Y BMC Cancer; 2022 Apr; 22(1):429. PubMed ID: 35443644 [TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model. Tan Z; Chen X; Zuo J; Fu S; Wang H; Wang J J Transl Med; 2023 Mar; 21(1):223. PubMed ID: 36973787 [TBL] [Abstract][Full Text] [Related]
16. Systematic Analysis of Tumor Stem Cell-related Gene Characteristics to Predict the PD-L1 Immunotherapy and Prognosis of Gastric Cancer. Wang C; Chen Y; Zhou R; Yang Y; Fang Y Curr Med Chem; 2024; 31(17):2467-2482. PubMed ID: 37936456 [TBL] [Abstract][Full Text] [Related]
17. Construction of a gene model related to the prognosis of patients with gastric cancer receiving immunotherapy and exploration of COX7A1 gene function. Wang SY; Wang YX; Shen A; Yang XQ; Liang CC; Huang RJ; Jian R; An N; Xiao YL; Wang LS; Zhao Y; Lin C; Wang CP; Yuan ZP; Yuan SQ Eur J Med Res; 2024 Mar; 29(1):180. PubMed ID: 38494472 [TBL] [Abstract][Full Text] [Related]
18. A Novel Cancer Stemness-Related Signature for Predicting Prognosis in Patients with Colon Adenocarcinoma. Wang W; Xu C; Ren Y; Wang S; Liao C; Fu X; Hu H Stem Cells Int; 2021; 2021():7036059. PubMed ID: 34691191 [TBL] [Abstract][Full Text] [Related]
19. Identification of prognostic gene signature associated with microenvironment of lung adenocarcinoma. Yue C; Ma H; Zhou Y PeerJ; 2019; 7():e8128. PubMed ID: 31803536 [TBL] [Abstract][Full Text] [Related]
20. Cancer Stemness Associated With Prognosis and the Efficacy of Immunotherapy in Adrenocortical Carcinoma. Shi X; Liu Y; Cheng S; Hu H; Zhang J; Wei M; Zhao L; Xin S Front Oncol; 2021; 11():651622. PubMed ID: 34367952 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]